Revolution Medicines company profile

RVMD · NASDAQ · USD

Compare Revolution Medicines
$162.69Change from previous close: −2.50%Absolute change: −$4.18

Close · November 17, 2026

Company profile

Revolution Medicines has 883 employees and is headquartered in Redwood City, United States.

Revolution Medicines, Inc. has been headquartered in Redwood City, California, since it was incorporated in 2014. The clinical-stage precision oncology company develops targeted therapies for RAS-addicted cancers. Its pipeline is built around RAS(ON) inhibitors that bind RAS variants and can be used alone or in combination with other RAS(ON) inhibitors, RAS companion inhibitors or other therapeutic agents. Daraxonrasib and zoldonrasib are part of a phase 3 registrational trial testing their combination in patients with first-line pancreatic ductal adenocarcinoma (1L PDAC), while elironrasib G12C is in early clinical development for solid tumors. Further development candidates include RMC-5127, RMC-0708 and RMC-8839.

In the fiscal year ended December 2025, the company reported a net loss of USD 1.1 billion. It employed 883 people.

Company facts

Industry
Biotechnology
Headquarters
700 Saginaw Drive, 94063, Redwood City
Employees
883
Chief executive
Mark Goldsmith
Founded
2014
Fiscal year
January - December
Listing
RVMD · NASDAQ
Currency
USD
ISIN
US76155X1000
Website
revmed.com

Revolution Medicines and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
Revolution MedicinesRVMDUnited States$37.27B883-853.0%—
Royalty PharmaRPRXUnited States$39.4B10064.4%45.4
BeOne MedicinesONCUnited States$46.98B12,00017.8%52.7
Roivant SciencesROIVUnited States$28.64B721-3,226.3%—
InsmedINSMUnited States$26.96B1,664-41.7%—
IncyteINCYUnited States$24.36B2,84432.2%61.0

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare Revolution Medicines with its competitors